Photo from archive.org
A literature based study on the health impacts of three platinum anticancer drugs (cisplatin, carboplatin and oxaliplatin) was undertaken. The published evidence for health benefits is presented and assessed. A… Click to show full abstract
A literature based study on the health impacts of three platinum anticancer drugs (cisplatin, carboplatin and oxaliplatin) was undertaken. The published evidence for health benefits is presented and assessed. A model was developed to quantify the health gain of adding platinum based drugs to cancer treatment at the population level for the UK and the USA. The economic value of using platinum drugs (in terms of qualityadjusted life year (QALY)) in addition to other cancer treatments can be estimated at over £556 million for the UK and over US$4.8 billion for the USA, depending on the scenario chosen.
Journal Title: Johnson Matthey Technology Review
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!